Deborah Harland

About

Deborah Harland was appointed Chair of the Ventures Investment Committee at LifeArc in October 2022. She has an exceptional track record in the life sciences sector, including 20 years at venture capital firm SR One, where she has served as partner and venture partner and currently acts as an advisor. Deborah is an independent investment committee member at British Patient Capital and a non-executive director at VHsquared. She has previously served on a number of boards as a non-executive director, including Cancer Research Horizons, Asceneuron, MISSION Therapeutics, MiroBio, f-star, Bicycle Therapeutics, Protaffin Biotechnologie, and Syntaxin. Deborah held senior positions in scientific licensing, business development and medical affairs at GSK and SmithKline Beecham. She was a British Heart Foundation/Wellcome Trust Postdoctoral Research fellow at University of Nottingham Medical School, has an MBA from Harvard Business School and a PhD in Pharmacology from University of London.

Source (opens in a new tab)